Jasbir Singh

Jasbir Singh

Director Director DIN 02161787
DIN 02161787 First appointment Dec 2009 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Jasbir Singh

Data last updated:

Jasbir Singh was a Director at Hfa Pharma Ethics Private Limited (2009–2019) and Designated Partner at Hfa Pharma Ethics Llp (from 2019). The companies operate in Trading.

DIN 02161787
Primary Designation Director
Industry Trading
First Appointment 01 Dec 2009
Oldest Company Age 7 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hfa Pharma Ethics Private Limited U24232DL2009PTC196490
Director01 Dec 20092009Converted To Llp
Designated Partner17 Jun 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hfa Pharma Ethics Llp
Hfa Pharma Ethics Private Limited
Premium access

Shareholding and investment profile for Jasbir Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jasbir Singh

Jasbir Singh was first appointed on 01 Dec 2009 as Director at Hfa Pharma Ethics Private Limited. The most recent appointment on record is 17 Jun 2019 at Hfa Pharma Ethics Llp.

Jasbir Singh held 2 earlier board appointments: Hfa Pharma Ethics Private Limited (Director, 01 Dec 2009 to 16 Jun 2019); Hfa Pharma Ethics Llp (Designated Partner, from 17 Jun 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available